Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,275,280 papers from all fields of science
Search
Sign In
Create Free Account
cidofovir hexadecyloxypropyl ester
Known as:
HDP-Cidofovir
, HDP-CDV
, Hexadecyloxypropyl-Cidofovir
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Narrower (2)
CMX001
brincidofovir
Broader (2)
Cytosine
Organophosphonates
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Synthesis and Early Development of Hexadecyloxypropylcidofovir: An Oral Antipoxvirus Nucleoside Phosphonate
K. Hostetler
Viruses
2010
Corpus ID: 11035217
Hexadecyloxypropyl-cidofovir (HDP-CDV) is a novel ether lipid conjugate of (S)-1-(3-hydroxy-2-phosphonoylmethoxypropyl)-cytosine…
Expand
Highly Cited
2010
Highly Cited
2010
1-O-Hexadecyloxypropyl Cidofovir (CMX001) Effectively Inhibits Polyomavirus BK Replication in Primary Human Renal Tubular Epithelial Cells
C. H. Rinaldo
,
R. Gosert
,
Eva Bernhoff
,
S. Finstad
,
H. Hirsch
Antimicrobial Agents and Chemotherapy
2010
Corpus ID: 21517813
ABSTRACT Antiviral drugs for treating polyomavirus BK (BKV) replication in polyomavirus-associated nephropathy or hemorrhagic…
Expand
Highly Cited
2009
Highly Cited
2009
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
K. Hostetler
Antiviral Research
2009
Corpus ID: 4045613
Highly Cited
2007
Highly Cited
2007
Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses
D. Quenelle
,
M. Prichard
,
+5 authors
E. Kern
Antimicrobial Agents and Chemotherapy
2007
Corpus ID: 41995776
ABSTRACT The combination of ST-246 and hexadecyloxypropyl-cidofovir or CMX001 was evaluated for synergistic activity in vitro…
Expand
2006
2006
Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro.
Nadejda Valiaeva
,
J. Beadle
,
K. Aldern
,
Julissa Trahan
,
K. Hostetler
Antiviral Research
2006
Corpus ID: 22559803
2004
2004
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
D. Smee
,
M. Wong
,
K. Bailey
,
J. Beadle
,
K. Hostetler
,
R. Sidwell
International Journal of Antimicrobial Agents
2004
Corpus ID: 35826784
Review
2004
Review
2004
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections
E. De Clercq
,
J. Neyts
Reviews in Medical Virology
2004
Corpus ID: 9946701
Several nucleoside and nucleotide analogues have been identified as potent antiviral agents with convincing activity against…
Expand
2004
2004
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Lingyun Cheng
,
K. Hostetler
,
+7 authors
W. Freeman
Investigative Ophthalmology and Visual Science
2004
Corpus ID: 24110319
PURPOSE In an earlier study, a novel intraocular drug-delivery system was reported in which hexadecyloxypropyl-phospho…
Expand
Highly Cited
2003
Highly Cited
2003
Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
K. Aldern
,
Stephanie L. Ciesla
,
Kristine L Winegarden
,
K. Hostetler
Molecular Pharmacology
2003
Corpus ID: 23773036
Recently, there has been renewed interest in finding orally active drugs against smallpox. Cidofovir (CDV) given by parenteral…
Expand
Highly Cited
2003
Highly Cited
2003
Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
Stephanie L. Ciesla
,
Julissa Trahan
,
+4 authors
K. Hostetler
Antiviral Research
2003
Corpus ID: 11299478
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE